16. QUARTERLY INFORMATION (UNAUDITED) (Tables)

12 Months Ended

Sep. 30, 2012

Quarterly Information Tables

Schedule of quaterly data from consolidated statements of operations

Fiscal 2012
	Three months ended December 31, 2011	Three months ended March 31, 2012	Three months ended June 30, 2012	Three months ended September 30, 2012	Year ended September 30, 2012
Revenue	$               5,024	$             106,543	$             35,000	$              108,043	$            254,610
Operating expenses	4,448,300	4,368,900	4,248,098	4,432,152	17,497,450
Non operating income (expenses)	(94,407)	(27,275)	(12,737)	(11,734)	(146,153)
Gain/(loss) on derivative instruments	956,470	(4,204,327)	3,390,389	1,769,151	1,911,683
Net loss	(3,581,213)	(8,493,959)	(835,446)	(2,566,692)	(15,477,310)
Issuance of additional shares due to reset provision	(250,000)	-	-	-	(250,000)
Modification of warrants	(325,620)	-	-	-	(325,620)
Inducement warrants	-	(1,593,000)	-	-	(1,593,000)
Net loss available to common shareholders	$      (4,156,833)	$      (10,086,959)	$         (835,446)	$         (2,566,692)	$     (17,645,930)
Net loss per share-basic	$               (0.02)	$                 (0.04)	$0.00	$                  (0.01)	$                (0.07)
Net loss per share-diluted	$               (0.02)	$                 (0.04)	$0.00	$                  (0.01)	$                (0.07)
Weighted average shares-basic and diluted	228,568,435	247,369,587	258,467,582	272,974,949	251,836,540
Fiscal 2011
	Three months ended December 31, 2010	Three months ended March 31, 2011	Three months ended June 30, 2011	Three months ended September 30, 2011	Year ended September 30, 2011
Revenue	$           662,818	$               43,815	$             77,403	$              172,118	$            956,154
Operating expenses	4,978,852	5,140,811	4,923,147	3,899,018	18,941,828
Non operating income (expenses)	11,477	5,305	(31,822)	(143,777)	(158,817)
Other expenses	-	(12,000,000)	-	-	(12,000,000)
Gain/(loss) on derivative instruments	(1,946,395)	3,062,087	1,763,311	1,553,145	4,432,148
Net loss	(6,250,952)	(14,029,604)	(3,114,255)	(2,317,532)	(25,712,343)
Modification of warrants	-	(1,068,369)	-	-	(1,068,369)
Net loss available to common shareholders	$      (6,250,952)	$      (15,097,973)	$      (3,114,255)	$         (2,317,532)	$     (26,780,712)
Net loss per share-basic	$               (0.03)	$                 (0.07)	$               (0.01)	$                  (0.01)	$                (0.13)
Net loss per share-diluted	$               (0.03)	$                 (0.09)	$               (0.02)	$                  (0.02)	$                (0.15)
Weighted average shares-basic and diluted	205,112,418	207,089,841	208,402,408	213,319,921	208,488,987